Article
type: Class

Document
type: Class

Information Content Entity
type: Class

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-24T06:35:25
publisher: A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer
type: Document
label: RDF description of A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer - http://irises.unisr.it/resource/item/102211

5686607
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer

Generically Dependent Continuant
type: Class

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer
type: Document
type: Entity
type: Generically Dependent Continuant
type: Academic Article
related by: 5686607
most specific type: Academic Article
type: Thing
type: Article
type: Information Content Entity
type: Continuant